High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.
about
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific RegionGuide for diagnosis and treatment of hepatocellular carcinomaCurrent role of ultrasound for the management of hepatocellular carcinomaHepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting.Hepatocellular carcinoma and hepatitis C in the United States.Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention.The changing pattern of epidemiology in hepatocellular carcinoma.Epidemiology of hepatocellular carcinoma: consider the population.Pathogenesis and management of alcoholic liver cirrhosis: a review.Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass.Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice.Could ADC values be a promising diagnostic criterion for differentiating malignant and benign hepatic lesions in Asian populations: A meta-analysis.XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Selection of Mesenchymal-Like Metastatic Cells in Primary Tumors - An in silico Investigation.Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography -- a randomised study.Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
P2860
Q26750444-496DB728-83F3-4CF3-9542-E0A7E35F5898Q28084003-4FEE63B9-94D3-4F63-AEC7-EE5F3787A2F3Q30488974-CACA3864-FB1C-4A55-A0AA-655FFD420E2DQ34000108-A8BD2C3D-A481-4758-85D5-3EF6D1CA3880Q34528514-A8B1D66E-CE24-465E-8E0E-B232F7281418Q34733981-A55F8580-46DC-4EB2-A458-BFFAF7EEBED1Q36084797-746578D1-B8D2-4D6B-A0CA-CD205C65C89DQ36930514-8668187F-52E2-4D42-9C26-DF00D69AEB7AQ37355613-4472CF25-0F29-4081-88C1-2D4870294153Q37669086-4662A07D-0445-4DA5-B62C-A264B1A1983EQ38046452-9733A7D4-0EC5-4F66-A41D-80EB6A5524E5Q39035163-92AA0C02-C26C-410D-82B6-003EC81E8661Q40449077-E0CEC691-6CD5-4743-8C6A-E5ECFD03BDD6Q41563902-26386877-F707-4B48-BFC7-1F0577A68FF2Q41962614-C9C8BACF-CE91-426D-A913-E98EFD4A3879Q42144113-E19F79C7-EB0E-41AA-B9D6-2609C994873DQ45163906-0B394E6B-61F0-4B42-A513-A00D4C9F001DQ50798940-1D6ED759-3666-4602-909B-997514E9E5FF
P2860
High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
High prevalence of multinodula ...... able to multiple risk factors.
@ast
High prevalence of multinodula ...... able to multiple risk factors.
@en
High prevalence of multinodula ...... able to multiple risk factors.
@nl
type
label
High prevalence of multinodula ...... able to multiple risk factors.
@ast
High prevalence of multinodula ...... able to multiple risk factors.
@en
High prevalence of multinodula ...... able to multiple risk factors.
@nl
prefLabel
High prevalence of multinodula ...... able to multiple risk factors.
@ast
High prevalence of multinodula ...... able to multiple risk factors.
@en
High prevalence of multinodula ...... able to multiple risk factors.
@nl
P2093
P356
P1433
P1476
High prevalence of multinodula ...... table to multiple risk factors
@en
P2093
P304
P356
10.1002/HEP.510290604
P407
P577
1999-06-01T00:00:00Z